Liver Cells Caught Between States: Inflammation Blocks Recovery in Alcohol Disease
Liver disease caused by heavy drinking poses a difficult clinical puzzle: once the damage is established, giving up alcohol may not automatically return the organ to health. A team from the University of Illinois Urbana-Champaign, Duke University, and Chan Zuckerberg Biohub Chicago has found a possible explanation. In alcohol-injured livers, hepatic cells get stuck in an in-between phase of regeneration. The problem starts with inflammation-related changes to RNA splicing, driven by abnormally low amounts of the protein ESRP2. With less ESRP2, repair-related proteins cannot enter the nucleus and accumulate in the cytoplasm instead.
To reach this conclusion, the scientists examined healthy liver samples and tissues from patients with alcohol-related hepatitis and cirrhosis. They observed that many hepatocytes in damaged organs remain suspended between a fully mature state and a state that supports recovery. This faulty RNA splicing affects thousands of genes and appears to be a central reason why the organ fails to regenerate effectively.
Toward New Therapies: Restoring RNA Splicing in Alcoholic Liver Disease
In experiments aimed at reversing these effects, researchers blocked a receptor on an inflammatory factor. That intervention raised ESRP2 levels, and RNA splicing returned to a more normal pattern. Although the approach is not yet ready for patients, it suggests potential routes for future treatment and diagnostic markers. Additional evidence came from mice without the ESRP2 gene: their livers exhibited injury and poor regeneration that closely resembled severe alcohol-induced damage in humans.
This work expands the scientific understanding of how the liver heals—and fails to heal—after alcohol injury. Pinpointing the molecular basis of stalled regeneration is a necessary step toward designing therapies that go beyond alcohol cessation.
Understanding exactly how ESRP2 and RNA splicing operate in the injured liver could reshape the clinical approach to alcohol-associated disease. It also highlights the broader value of molecular discovery in medicine, where progress often depends on deciphering cellular barriers before effective treatments can emerge.
Understanding the complexities of liver recovery is crucial, as recent findings highlight that abstaining from alcohol alone may not suffice for healing. In a related study, researchers have identified a brain signal that could indicate the likelihood of relapse after alcohol cessation. This connection underscores the intricate relationship between liver health and the neurological factors influencing recovery.